Quintrio
Home

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Attovia Therapeutics, Inc. Common Stock

ATTO

Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.

Last trade $14.77
Day change +$0.045 (+0.31%)
Day range $14.16 – $14.96
Volume 151,162
Market cap $673M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

No ratio data was found for ATTO.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for ATTO, quarterly periods
Line itemQ3 FY2026 Sep 30, 2026
Revenue$0
Cost of revenue$0
Gross profit$0
Selling, general and administrative$4.73M
Research and development$20.29M
Total operating expenses$25.02M
Operating income-$25.02M
Interest expense$0
Income before taxes-$22.27M
Income taxes$0
Net income-$22.27M
Net income attributable to common shareholders-$22.27M
EBITDA-$24.78M
Basic earnings per share-$0.76
Diluted earnings per share-$0.76

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Benzinga

Why Nocera Are Trading Higher By Around 89%; Here Are 20 Stocks Moving Premarket

Gainers Nocera, Inc. (NASDAQ: NCRA) shares surged 88.7% to $5.17 in pre-market trading after the company announced plans to acquire Zhe Jiang Xin Shui Hu Digital Information, Ltd. Impel Pharmaceuticals Inc. (NASDAQ: IMPL) shares gained 30.7% to $1.66 in pre-market trading. The company was granted U.S. Patent Respiratory Tract Delivery of Levodopa And Dopa Decarboxylase Inhibitor for the treatment of Parkinson's disease. iMedia Brands, Inc. (NASDAQ: IMBI) shares rose 27.4% to $0.1510 in pre-market trading after dropping 10% on Monday. iMedia Brands recently announced receipt of second Nasdaq non-compliance notice. SMX (Security Matters) Public Limited Company (NASDAQ: SMX) gained 15.2% to $0.1673 in pre-market trading after gaining 14% on Monday. SMX recently priced a $3.2 million public offering. Caravelle International Group (NASDAQ: CACO) shares rose 13.9% to $0.6502 in pre-market trading after gaining 14% on Monday. Caravelle, last month, reported receipt of Nasdaq notification regarding minimum bid price deficiency. ReTo Eco-Solutions, Inc. (NASDAQ: RETO) shares gained 12.7% to $1.33 in pre-market trading. ReTo recently ...

Benzinga

Why Li Auto Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Monday's Session

Gainers PolyMet Mining Corp. (NYSE: PLM) shares surged 144% to $1.92 after the company announced Glencore made a non-binding proposal to acquire the company for $2.11 per share. Fresh Vine Wine, Inc. (NYSE: VINE) gained 70.1% to $0.3845. Fresh Vine Wine recently announced the appointment of Hitesh Dheri as Chief Financial Officer and Secretary. Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares jumped 65.1% to $6.32. Advanced Health Intelligence recently announced the implementation of an ADS ratio change. SQZ Biotechnologies Company (NYSE: SQZ) shares gained 46.1% to $0.3944 after declining 11% on Friday. IMAC Holdings, Inc. (NASDAQ: BACK) shares jumped 38.6% to $0.1524. Theralink recently signed definitive merger agreement to be acquired by IMAC Holdings. Canopy Growth Corporation (NASDAQ: CGC) gained 37% to $0.5337. Canopy Growth said that all conversions pursuant to the $100 million senior unsecured convertible debentures, sold to an institutional investor in February 2023, have been completed. Ensysce Biosciences, Inc. (NASDAQ: ENSC) gained 30.6% to $2.39. HC Wainwright & Co. initiated coverage on Ensysce Biosciences with a Buy rating and announced a price target of $9. Spark Networks SE (NASDAQ: LOV) rose 26.1% to $0.3974. Nemaura Medical Inc. (NASDAQ: NMRD) surged 24.6% to $1.16. Ventyx Biosciences, Inc. (NASDAQ: VTYX) gained 17.6% to $38.56. Journey Medical Corporation (NASDAQ: DERM) jumped 17.6% to $1.87. Journey Medical expects topline results from the Phase 3 clinical trials evaluating DFD-2 for the treatment of papulopustular rosacea to be announced week of July 10, 2023. ACM Research, Inc. (NASDAQ: ACMR) shares climbed 17% to $15.30 after Jefferies upgraded its rating from Underperform to Buy and raised the price target from $9 to $23.4. Micromobility.com Inc. (NASDAQ: MCOM) shares ...

Benzinga

Nasdaq Edges Lower; ISM Manufacturing PMI Drops In June

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite trading lower on Monday. The Dow traded up 0.16% to 34,462.62 while the NASDAQ fell 0.03% to 13,784.02. The S&P 500, also rose, gaining, 0.07% to 4,453.57. Check This Out: This Analyst With 84% Accuracy Rate Sees Around 19% Upside In Amazon.com - Here Are 5 Stock Picks For June From Wall Street's Most Accurate Analysts   Leading and Lagging Sectors Consumer discretionary shares jumped by 1.3% on Monday. In trading on Monday, health care shares fell by 1%.   Top Headline The ISM manufacturing PMI in the U.S. declined to 46 in June from 46.9 in the prior month and down from market estimates of 47.   Equities Trading UP Ensysce Biosciences, Inc. (NASDAQ: ENSC) shares shot up 16% to $2.1275. HC Wainwright & Co. initiated coverage on Ensysce Biosciences with a Buy rating and announced a price target of $9. Shares of PolyMet Mining Corp. (NYSE: PLM) got a boost, shooting 150% to $1.9721 after the company announced Glencore made a non-binding proposal to acquire the company for $2.11 per share. Canopy Growth Corporation (NASDAQ: CGC) shares were also up, gaining 45% to $0.5628 after the company announced it completed all conversions pursuant to the $100 million convertible debentures and provided an update to its balance sheet actions taken to date.   Equities Trading ...

Benzinga

Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers QualTek Services Inc. (NASDAQ: QTEK) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy. T2 Biosystems, Inc. (NASDAQ: TTOO) shares climbed 99.4% to $0.1886 after the company reported second largest sepsis-driven instrument sale in company history. Aclarion, Inc. (NASDAQ: ACON) climbed 69% to $1.0430 after the company announced a commercial agreement with the London Clinic and London Spine Clinic Arlington Asset Investment Corp. (NASDAQ: AAIC) shares gained 50.1% to $4.1285 after Ellington Financial announced plans to acquire the company. GreenLight Biosciences Holdings (NASDAQ: GRNA) rose 37.8% to $0.2750 after the company announced it entered into a definitive agreement to be acquired by a group of buyers led by Fall Line Capital in an all-cash transaction valuing the company at approximately $45.5 million. Equitrans Midstream Corporation (NYSE: ETRN) gained 37.4% to $8.35 after RBC Capital upgraded the stock from Sector Perform to Outperform and raised its price target from $7 to $10. GD Culture Group Limited (NASDAQ: GDC) gained 31.3% to $5.83. Atento S.A. (NYSE: ATTO) shares surged 30.6% to $1.91 after gaining 8% on Friday. Monopar Therapeutics Inc. (NASDAQ: MNPR) rose 30% to $1.1726. Babylon Holdings Limited (NASDAQ: BBLN) surged 25.6% to $0.66. PyroGenesis Canada Inc. (NASDAQ: PYR) gained 24.6% to $0.8328. Ideanomics, Inc. (NASDAQ: IDEX) rose 22.6% to $0.0466. Taro Pharmaceutical Industries Ltd. (NYSE: TARO) surged 22.5% to $36.01. Fanhua Inc. (NASDAQ: FANH) climbed 18.8% to $7.69 following first-quarter results. Ashford Inc. (NYSE: AINC) rose 17.6% to $10.89. Virios Therapeutics, Inc. (NASDAQ: VIRI) gained 17.4% to $1.69. Virios Therapeutics recently regained compliance with Nasdaq minimum bid price requirement. mCloud Technologies Corp. (NASDAQ: MCLD) jumped 14.6% to $0.6150. mCloud Technologies recently formed a special committee for the purpose of exploring strategic alternatives. Iovance Biotherapeutics, Inc. ...

PennyStocks

Penny Stocks To Buy? 3 AI Stocks To Watch Right Now

AI penny stocks to watch this week. The post Penny Stocks To Buy? 3 AI Stocks To Watch Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

Ex-dividendAmount / sharePay dateType
Nov 9, 2017$1.7092Nov 28, 2017unknown

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Jul 30, 20201-for-5.027reverse split